Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume 23, Issue 4, Pages 617-627
Publisher
Oxford University Press (OUP)
Online
2017-03-15
DOI
10.1097/mib.0000000000001067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The α4β1 Homing Pathway Is Essential for Ileal Homing of Crohnʼs Disease Effector T Cells In Vivo
- (2017) Sebastian Zundler et al. INFLAMMATORY BOWEL DISEASES
- Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis
- (2016) Gaik W. Tew et al. GASTROENTEROLOGY
- Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells and endothelium and modulated during inflammatory bowel disease
- (2016) T Karuppuchamy et al. Mucosal Immunology
- Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
- (2016) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease
- (2015) B. G. Feagan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Natalizumab for Crohn’s Disease: Down but Not Out
- (2015) Frank I. Scott et al. Clinical Gastroenterology and Hepatology
- Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis
- (2015) William J. Sandborn et al. GASTROENTEROLOGY
- Safety and Efficacy of AJM300, an Oral Antagonist of α4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis
- (2015) Naoki Yoshimura et al. GASTROENTEROLOGY
- Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo
- (2015) Anika Fischer et al. GUT
- T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate
- (2015) Laura K. Mackay et al. IMMUNITY
- Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients
- (2015) Edward Shelton et al. INFLAMMATORY BOWEL DISEASES
- Enrichment of Circulating and Mucosal Cytotoxic CD8+T Cells Is Associated with Postoperative Endoscopic Recurrence in Patients with Crohn’s Disease
- (2015) Gilles Boschetti et al. Journal of Crohns & Colitis
- OP021. TURANDOT: a randomized, multicenter double-blind, placebo-controlled study of the safety and efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in patients with moderate to severe Ulcerative Colitis (UC)
- (2015) Journal of Crohns & Colitis
- Vedolizumab Effectiveness and Safety Over the First Year of Use in an IBD Clinical Practice
- (2015) Emily E. Vivio et al. Journal of Crohns & Colitis
- Efficacy and Safety of Antiintegrin Antibody for Inflammatory Bowel Disease
- (2015) Lianjie Lin et al. MEDICINE
- Regulatory T-cell depletion in the gut caused by integrin β7 deficiency exacerbates DSS colitis by evoking aberrant innate immunity
- (2015) H L Zhang et al. Mucosal Immunology
- The emerging role of resident memory T cells in protective immunity and inflammatory disease
- (2015) Chang Ook Park et al. NATURE MEDICINE
- Exit Strategies: S1P Signaling and T Cell Migration
- (2015) Audrey Baeyens et al. TRENDS IN IMMUNOLOGY
- IL-9 and its receptor are predominantly involved in the pathogenesis of UC
- (2014) Nancy Nalleweg et al. GUT
- Tissue-Resident Memory T Cells
- (2014) Jason M. Schenkel et al. IMMUNITY
- Intestinal dendritic cells in the regulation of mucosal immunity
- (2014) Vasileios Bekiaris et al. IMMUNOLOGICAL REVIEWS
- A CD8+/CD103high T Cell Subset Regulates TNF-Mediated Chronic Murine Ileitis
- (2014) J. Ho et al. JOURNAL OF IMMUNOLOGY
- NOD2 Regulates CXCR3-Dependent CD8+ T Cell Accumulation in Intestinal Tissues with Acute Injury
- (2014) X. Wu et al. JOURNAL OF IMMUNOLOGY
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells
- (2014) Katharina Gerlach et al. NATURE IMMUNOLOGY
- Role and species-specific expression of colon T cell homing receptor GPR15 in colitis
- (2014) Linh P Nguyen et al. NATURE IMMUNOLOGY
- In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
- (2014) Raja Atreya et al. NATURE MEDICINE
- Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis
- (2013) Joshua J. Chalkley et al. Current Neurology and Neuroscience Reports
- Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
- (2013) Lloyd Mayer et al. GUT
- Transforming Growth Factor-β Signaling Controls the Formation and Maintenance of Gut-Resident Memory T Cells by Regulating Migration and Retention
- (2013) Nu Zhang et al. IMMUNITY
- In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytes
- (2013) Tim Wyant et al. mAbs
- Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells
- (2013) Cara N Skon et al. NATURE IMMUNOLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease
- (2013) Satish Keshav et al. PLoS One
- GPR15-Mediated Homing Controls Immune Homeostasis in the Large Intestine Mucosa
- (2013) S. V. Kim et al. SCIENCE
- Chemokine-triggered leukocyte arrest: force-regulated bi-directional integrin activation in quantal adhesive contacts
- (2012) Ronen Alon et al. CURRENT OPINION IN CELL BIOLOGY
- A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
- (2012) Paul J Rutgeerts et al. GUT
- Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates
- (2012) Eric R. Fedyk et al. INFLAMMATORY BOWEL DISEASES
- Differing Requirements for CCR4, E-Selectin, and 4 1 for the Migration of Memory CD4 and Activated T Cells to Dermal Inflammation
- (2012) A. Gehad et al. JOURNAL OF IMMUNOLOGY
- T cell homing to epithelial barriers in allergic disease
- (2012) Sabina A Islam et al. NATURE MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1
- (2011) Carmen Bozic et al. ANNALS OF NEUROLOGY
- The Chemokine Receptor CCR9 Is Required for the T-Cell–Mediated Regulation of Chronic Ileitis in Mice
- (2011) Joshua D. Wermers et al. GASTROENTEROLOGY
- Gut-Tropic T Cells That Express Integrin α4β7 and CCR9 Are Required for Induction of Oral Immune Tolerance in Mice
- (2011) Barbara Cassani et al. GASTROENTEROLOGY
- Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
- (2011) Warren Strober et al. GASTROENTEROLOGY
- The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study
- (2011) S. Vermeire et al. GUT
- Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study
- (2011) Asit Parikh et al. INFLAMMATORY BOWEL DISEASES
- CD8+ T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung
- (2011) Berber Piet et al. JOURNAL OF CLINICAL INVESTIGATION
- Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis
- (2011) James C. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- CCL25/CCR9 Interactions Regulate Large Intestinal Inflammation in a Murine Model of Acute Colitis
- (2011) Marc-Andre Wurbel et al. PLoS One
- CD8+CD122+ Regulatory T Cells (Tregs) and CD4+ Tregs Cooperatively Prevent and Cure CD4+ Cell-Induced Colitis
- (2010) A. T. Endharti et al. JOURNAL OF IMMUNOLOGY
- Role of β7 Integrins in Intestinal Lymphocyte Homing and Retention
- (2009) G. Gorfu et al. CURRENT MOLECULAR MEDICINE
- Gut Homing Receptors on CD8 T Cells Are Retinoic Acid Dependent and Not Maintained by Liver Dendritic or Stellate Cells
- (2009) Bertus Eksteen et al. GASTROENTEROLOGY
- The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti- 4 7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
- (2009) D. Soler et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules
- (2009) David Marsolais et al. NATURE REVIEWS DRUG DISCOVERY
- CD4 T-cell differentiation and inflammatory bowel disease
- (2009) Lauren A. Zenewicz et al. TRENDS IN MOLECULAR MEDICINE
- IL-6–dependent spontaneous proliferation is required for the induction of colitogenic IL-17–producing CD8+T cells
- (2008) Masaki Tajima et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Failure of T cell homing, reduced CD4/CD8 intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice
- (2008) S. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T-cell recruitment to the intestinal mucosa
- (2008) William W. Agace TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now